So let me ask you what do you see they can get for this company? Or there waiting for the Pay day for match what do you think?Total milestone payments under the agreement, excluding royalties, could reach up to approximately $80 million for each target program.you see under the terms of the agreement, Tranzyme will be primarily responsible for early lead discovery, and Bristol-Myers Squibb will take primary responsibility for optimizing the identified lead compounds. BMS will be solely responsible for completing preclinical and clinical development of all products arising from the collaboration, and for their commercialization globally!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.